Sangamo BioSciences (SGMO) Year-over-year net earnings per share growth for the last 12 months

Brandmark of Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics (SGMO) is implementing automated bioreactors to minimize errors during drug development. Reviewing the quarterly EPS trajectory on GURU.Markets reveals a neutral momentum, where 0.50 expresses the current value of the metric. Growth prospects are based on treating Alzheimer's disease via "zinc fingers," while financial stability relies on licensing payments from major pharma partners for patent access.

SGMO: sangamo.com Year-over-year earnings per share growth rate for the last twelve months 07/04/2022 - 05/09/2026

Analytical breakdowns for Sangamo Therapeutics

- market value and analyst target forecast:
Summary company analytics:Sangamo Therapeutics Inc. - SGMO
Flagship merchandise of Sangamo Therapeutics

Sangamo Therapeutics (SGMO) is advancing genomic medicine through strategic alliances with Pfizer and other industry leaders. The effectiveness of such partnerships directly impacts earnings per share (EPS) dynamics, reflecting the financial outcomes of joint development efforts. This indicator measures the percentage change in net income per share on a quarterly basis. It allows investors to track the issuer's fundamental strength between official reports. Comparing quarterly EPS helps investors avoid overpaying at the peak of growth.

Competitor analysis

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|4dmoleculartherapeutics.com (FDMT) - Year-over-year net earnings per share growth for the last 12 months|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Korro Bio, Inc (KRRO) - Quarterly EPS earnings growth|EDIT (editasmedicine.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SLN (silence-therapeutics.com)|Year-over-year earnings per share growth for the last twelve months proqr.com (PRQR)|Codexis - Year-over-year earnings per share growth for the last 12 months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)